In this article we report a case of pulmonary alveolar microlithiasis who presented with progressive dyspnea on exersion, and was diagnosed based on typical imaging findings, obviating the need for lung biopsy.
Case presentation
A 67-year-old female presented with complaints of slowly progressive shortness of breath on exertion and intermittent dry cough for 7 years. She was a nonsmoking teacher with no previously known pulmonary disease until 2012. She was suspected to have an interstitial lung disease because of perCompeting Interests: The authors declare that there is no conflict of interest regarding the publication of this paper.
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sistent bilateral infiltrates on chest xray (CXR) ( Fig. 1 ) ; however, no further workup was done at that time. She denied fever or hemoptysis. She was treated empirically multiple times in the past with steroids with no improvement in her symptoms. On physical examination, she was found to be tachypnic RR 24, and hypoxemic with SpO 2 of 87% on room air improved to 92% on 2 L nasal O 2 . Bilateral fine crackles were noted on auscultation with finger clubbing but no peripheral edema. Routine biochemistry including serum calcium and phosphorus were normal.
A microlithiasis. A chest CT showed diffuse calcifications in the form of intra-alveolar microliths, calcified interlobular septa, and diffuse ground-glass attenuation with septal thickening ( Figs. 2,3 ) . To further confirm the diagnosis Technetium 99 mmethylene diphosphonate bone scan was done, and showed diffuse radiotracer uptake ( Fig. 4 ) . These finding were deemed adequate to establish a diagnosis of pulmonary alveolar microlithiasis (PAM). Patient refused lung transplant referral on discharge and she was provided with 3 L nasal O 2 after assessed for home oxygen requirement.
Discussion
PAM is a rare autosomal recessive disease with high penetrance, in which concretions composed of calcium phosphate fill alveolar spaces, despite normal serum calcium and phosphorus, and absence of any systemic disease of calcium metabolism [2] . Over 1000 cases were reported worldwide especially in Mediterranean countries [3] . Several mutations in the gene SLC34A2 on chromosome 4p15.2 are well known to cause the disease [1, 4] . This disease is typically diagnosed accidently between 30 and 50 years of age with no significant gender differences found. The golden key in the diagnosis of this disease is clinical-radiological dissociation as patients have less severity of symptoms compared to radiologic finding. Symptomatic patients tend to have dyspnea, as well as a nonproductive cough, mainly on exertion. Blood chemistry tests usually produce results within the normal range. Chest radiographic findings in PAM show diffuse, sandstorm-like infiltration, particularly in lower bases. Chest radiographs may include black pleura sign seen as a strip of tangential peripheral lucency underlying the ribs as compared to the adjacent diffusely dense calcified lung. CT scan of the chest shows numerous sandstorm-like calcifications throughout the lungs with subpleural and peribronchial distribution. Bone scintigraphy using technetium-99m labeled diphosphonate compounds have affinity for calcification foci at soft tissue and can detect early pulmonary calcification [5] . Histopathology is not always required and it is done by open lung or transbronchial biopsy, showing intra-alveolar laminated calcium phosphate concretions. There is no treatment available for this disease. Thus, long-term oxygen therapy is required for hypoxemia and chronic respiratory failure. In our patient lung biopsy was not performed as she had typical findings on the bone scan.
